|
AU2013204450A1
|
|
Compounds useful for treating neurodegenerative disorders
|
|
WO2013036684A1
|
|
Compounds useful for treating neurodegenerative disorders
|
|
TW201317256A
|
|
Compounds for use in treating neurodegenerative disorders, synthesis thereof, and intermediates thereto
|
|
TW201317257A
|
|
Compounds useful for treating neurodegenerative disorders
|
|
WO2013036671A1
|
|
Compounds useful for treating neurodegenerative disorders
|
|
WO2013036679A1
|
|
Compounds useful for treating neurodegenerative disorders
|
|
WO2013036678A1
|
|
Compounds useful for treating neurodegenerative disorders
|
|
WO2013036674A1
|
|
Compounds useful for treating neurodegenerative disorders
|
|
AU2012211415A1
|
|
Compounds useful for treating neurodegenerative disorders
|
|
CN102939011A
|
|
Compounds useful for treating neurodegenerative disorders
|
|
US2010144689A1
|
|
Compounds useful for treating neurodegenerative disorders
|
|
EP2083621A2
|
|
Modulators of amyloid-beta production
|
|
EP2073638A2
|
|
Synthesis of compounds useful as modulators of amyloid-beta production
|
|
KR20090087075A
|
|
Compounds useful for treating neurodegenerative disorders
|
|
CA2609021A1
|
|
Compounds useful for treating neurodegenerative disorders
|
